by John Conrad | Aug 20, 2025 | iBIO News, Policy News
The Illinois Biotechnology Innovation Organization (iBIO) delivered a coalition lettercoalition letter signed by 74 companies and organizations from across Illinois to the state’s U.S. Congressional delegation, urging immediate action to reauthorize the Small Business...
by John Conrad | Aug 14, 2025 | iBIO News
The latest Government Bioscience Grants (GBG) report from G2G Consulting identifies 78 non-dilutive funding opportunities across critical biotech research areas. Key Opportunities Combat Medicine: DARPA’s MASH program seeks autonomous technologies for finding...
by John Conrad | Aug 8, 2025 | iBIO in the News
Of the $1.24 billion in venture investments pumped into Illinois’ life sciences sector last year, about half went to the state’s late-stage companies, Series A rounds accounted for 35% and early-stage companies collected 15% of the funding, according to a...
by John Conrad | Aug 5, 2025 | iBIO News
Report highlights nearly 100 life science companies and investment trends as Chicago prepares to welcome BIO International Convention 2030 CHICAGO, IL – August 5, 2025 – The Illinois Biotechnology Innovation Organization (iBIO) today released its inaugural Member...
by John Conrad | Aug 4, 2025 | Policy News
Illinois companies stand to lose $90 million in annual funding if federal programs expire September 30th Illinois life sciences companies and associations have until August 15th to sign onto a group letter urging the state’s Congressional Delegation to...
by John Conrad | Aug 1, 2025 | Member News, NewsBrief
Chicago biotech startup ClostraBio has secured GRAS (Generally Recognized as Safe) status for its flagship probiotic ingredient CLB101™, clearing the path for the first commercially available strain of Anaerostipes caccae in the U.S. What Makes It Different Unlike...
by Monique Naleway | Jun 6, 2025 | STEM Heros
by Monique Naleway | Jun 6, 2025 | STEM Heros
by John Conrad | May 12, 2025 | Policy News
“The President’s Most Favored Nation proposal represents a catastrophic misstep for American biosciences innovation and patient access to life-saving treatments,” said John Conrad, President and CEO of the Illinois Biotechnology Innovation Organization. “This...
by John Conrad | Apr 22, 2025 | iBIO News
Amritha Praveen, a sophomore at Adlai E. Stevenson High School, has been named the champion of the 2025 Illinois BioGENEius Challenge. Praveen impressed the panel of industry judges with her groundbreaking research project titled “Early Risk Assessment of Autism...
